Beta Bionics (BBNX) Inventory Average (2025 - 2026)

Beta Bionics' (BBNX) quarterly Inventory Average came in at $22.7 million in Q1 2026, up 56.45% year-on-year from $14.5 million in Q1 2025, and up 7.97% quarter-over-quarter from $21.0 million in Q4 2025.

Beta Bionics (BBNX) Inventory Average (2025 - 2026) Analysis & Trends

Beta Bionics has disclosed Inventory Average across 2 years of filings, most recently posting $22.7 million for Q1 2026.

  • Inventory Average for Q1 2026 came in at $22.7 million, up 56.45% year-over-year; the trailing twelve-month figure through Mar 2026 was $22.7 million (up 56.45% YoY), and the FY2025 annual result was $17.5 million, up 140.59% from the prior year.
  • Inventory Average came in at $22.7 million for Q1 2026 at Beta Bionics, up from $21.0 million in the prior quarter.
  • In the past five years, Inventory Average ranged from a high of $22.7 million in Q1 2026 to a low of $14.5 million in Q1 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Inventory Avg. (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn 6.74 Bn
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn 5.36 Bn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn 6.23 Bn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn 3.03 Bn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn 1.12 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 3.49 Bn
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn 661.35 Mn
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn 2.29 Bn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn 652.65 Mn
10 Beta Bionics 617.66 Mn 587.36 Mn 16.44 Mn 22.72 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 22.72 Mn
Dec 31, 2025 21.05 Mn
Sep 30, 2025 18.85 Mn
Jun 30, 2025 16.53 Mn
Mar 31, 2025 14.53 Mn